Shrikant Anant

12.2k citations
212 papers · 9.3k indexed · 1 hit paper · h-index 56

Shrikant Anant

201 papers receiving 9.1k citations

Hit Papers

Specific Expression of Activation-induced Cytidine Deamin...19992026200820171999250500750

Peers

Shrikant Anant
Comparison fields: 5 of 148
  • Molecular Biology 5.3k
  • Oncology 2.2k
  • Cancer Research 1.5k
  • Immunology 1.5k
  • Genetics 840
Replace Georg Feldmann with:
Georg Feldmann Germany
Xia Zhao China
Spiridione Garbisa Italy
Igor B. Roninson United States
Rajani Ravi United States
Gabriella D’Orazi Italy
Andrew Thorburn United States
Hiroaki Sakurai Japan
Vinay Tergaonkar Singapore
Kam M. Hui Singapore
Shrikant Anant relative to Georg Feldmann Germany Georg Feldmann's profile →
Citations per field
00.5×2.8×
Georg Feldmann · 1×
Citations per year

Countries citing papers authored by Shrikant Anant

Since Specialization
Citations

This map shows the geographic impact of Shrikant Anant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shrikant Anant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shrikant Anant more than expected).

Fields of papers citing papers by Shrikant Anant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shrikant Anant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shrikant Anant. The network helps show where Shrikant Anant may publish in the future.

Co-authorship network of co-authors of Shrikant Anant

This figure shows the co-authorship network connecting the top 25 collaborators of Shrikant Anant. A scholar is included among the top collaborators of Shrikant Anant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shrikant Anant. Shrikant Anant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 20
2 12
3 16
4 12
5 11
6 13
7 4
8 59
9 17
10 44
11 145
12 19
13 93
14 169
15 15
16 13
17 49
18 137
19 133
20 15

About Shrikant Anant

Shrikant Anant is a scholar working on Molecular Medicine, Cancer Research and Oncology, having authored 212 papers that have together received 9.3k indexed citations. Recurring topics across this work include RNA Research and Splicing (25 papers), RNA modifications and cancer (20 papers) and RNA regulation and disease (18 papers). The work is most often cited by research in Molecular Medicine (520 citations), Cancer Research (1.5k citations) and Oncology (2.2k citations). Shrikant Anant has collaborated with scholars based in United States, India and France. Frequent co-authors include Dharmalingam Subramaniam, Nicholas O. Davidson, Courtney W. Houchen, Brian K. Dieckgraefe, Prasad Dandawate, Randal May, Sripathi M. Sureban, Animesh Dhar, Satish Ramalingam and Manabu Sugai. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026